Search

Jennifer I. Thissell

Examiner (ID: 4322)

Most Active Art Unit
3635
Art Unit(s)
3635
Total Applications
376
Issued Applications
300
Pending Applications
27
Abandoned Applications
49

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17256754 [patent_doc_number] => 20210369739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => COMBINATION THERAPY OF ACYLTHIOUREA COMPOUND AND ABIRATERONE [patent_app_type] => utility [patent_app_number] => 17/277090 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9698 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277090 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/277090
COMBINATION THERAPY OF ACYLTHIOUREA COMPOUND AND ABIRATERONE Sep 17, 2019 Pending
Array ( [id] => 17399482 [patent_doc_number] => 20220041572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => CYCLOHEPTYL ACIDS AS LPA ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 17/276178 [patent_app_country] => US [patent_app_date] => 2019-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276178 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/276178
CYCLOHEPTYL ACIDS AS LPA ANTAGONISTS Sep 15, 2019 Abandoned
Array ( [id] => 17123538 [patent_doc_number] => 20210298306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/275902 [patent_app_country] => US [patent_app_date] => 2019-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275902 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/275902
PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS Sep 11, 2019 Abandoned
Array ( [id] => 17343563 [patent_doc_number] => 20220009894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/289709 [patent_app_country] => US [patent_app_date] => 2019-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 1372 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289709 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/289709
1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Sep 11, 2019 Abandoned
Array ( [id] => 17399539 [patent_doc_number] => 20220041629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => ESTROGEN RECEPTOR TARGETING ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 17/275860 [patent_app_country] => US [patent_app_date] => 2019-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7689 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/275860
ESTROGEN RECEPTOR TARGETING ANTAGONISTS Sep 10, 2019 Pending
Array ( [id] => 17413984 [patent_doc_number] => 20220048888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/275609 [patent_app_country] => US [patent_app_date] => 2019-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24477 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275609 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/275609
PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE Sep 10, 2019 Pending
Array ( [id] => 17200052 [patent_doc_number] => 20210340147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => 2,6-DIMETHYL-N-((PYRIDlN-4-YL)METHYL)IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE AND 2,5-DIMETHYL-N-[(PYRIDlN-4-YL)METHYL]PYRAZOLO[1,5-A]PYRIMIDlN-7-AMINE DERIVATIVES FOR TREATING VIRAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/282064 [patent_app_country] => US [patent_app_date] => 2019-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9621 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282064 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/282064
2,6-dimethyl-n-((pyridin-4-yl)methyl)imidazo[1,2-b]pyridazin-8-amine and 2,5-dimethyl-n-[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine derivatives for treating viral infections Aug 19, 2019 Issued
Array ( [id] => 17154835 [patent_doc_number] => 20210315886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => IMIDAZOTETRAZINE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/266770 [patent_app_country] => US [patent_app_date] => 2019-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266770 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/266770
IMIDAZOTETRAZINE COMPOUNDS Aug 8, 2019 Pending
Array ( [id] => 17828367 [patent_doc_number] => 20220265671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => METHOD FOR TREATING STROKE BY USING TRICYCLIC DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/630700 [patent_app_country] => US [patent_app_date] => 2019-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630700 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/630700
METHOD FOR TREATING STROKE BY USING TRICYCLIC DERIVATIVE Jul 28, 2019 Abandoned
Array ( [id] => 17214391 [patent_doc_number] => 20210347728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => 4,5-DIHYDROXY-2-(4-METHYLBENZYL)ISOPHTHALONITRILE SOLVATES AND CRYSTALLINE FORMS THEREOF [patent_app_type] => utility [patent_app_number] => 17/262249 [patent_app_country] => US [patent_app_date] => 2019-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4123 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262249 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/262249
4,5-DIHYDROXY-2-(4-METHYLBENZYL)ISOPHTHALONITRILE SOLVATES AND CRYSTALLINE FORMS THEREOF Jul 23, 2019 Abandoned
Array ( [id] => 19777361 [patent_doc_number] => 12226381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Composition of fused tricyclic gamma-amino acid derivatives and the preparation thereof [patent_app_type] => utility [patent_app_number] => 17/259757 [patent_app_country] => US [patent_app_date] => 2019-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 16804 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259757 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/259757
Composition of fused tricyclic gamma-amino acid derivatives and the preparation thereof Jul 11, 2019 Issued
Array ( [id] => 17170279 [patent_doc_number] => 20210323949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => COMPOUNDS AND METHODS FOR INHIBITION OF MULTIPLE MYELOMA [patent_app_type] => utility [patent_app_number] => 17/272135 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272135 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/272135
COMPOUNDS AND METHODS FOR INHIBITION OF MULTIPLE MYELOMA Jun 27, 2019 Abandoned
Array ( [id] => 17791936 [patent_doc_number] => 20220251027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => BENZIDINE COMPOUND AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/438067 [patent_app_country] => US [patent_app_date] => 2019-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8349 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438067 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/438067
Benzidine compound and application thereof Jun 4, 2019 Issued
Array ( [id] => 16868399 [patent_doc_number] => 20210161866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => DRUG FOR USE IN COMBINATION, AND USE THEREOF FOR PREPARING DRUGS FOR TREATMENT OF HIGH-GRADE BRAIN TUMORS IN RESPONSE TO INEFFECTIVE STANDARD TREATMENT FOR POSTOPERATIVE RECURRENCE [patent_app_type] => utility [patent_app_number] => 17/053037 [patent_app_country] => US [patent_app_date] => 2019-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5288 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/053037
DRUG FOR USE IN COMBINATION, AND USE THEREOF FOR PREPARING DRUGS FOR TREATMENT OF HIGH-GRADE BRAIN TUMORS IN RESPONSE TO INEFFECTIVE STANDARD TREATMENT FOR POSTOPERATIVE RECURRENCE Apr 29, 2019 Abandoned
Array ( [id] => 19969623 [patent_doc_number] => 12338214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-24 [patent_title] => Bexarotene derivatives and their use in treating cancer [patent_app_type] => utility [patent_app_number] => 16/971736 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11573 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971736 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/971736
Bexarotene derivatives and their use in treating cancer Feb 28, 2019 Issued
Array ( [id] => 17472412 [patent_doc_number] => 20220079916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS [patent_app_type] => utility [patent_app_number] => 17/425608 [patent_app_country] => US [patent_app_date] => 2019-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7797 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425608 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/425608
USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS Jan 23, 2019 Abandoned
Array ( [id] => 16824204 [patent_doc_number] => 20210139497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => THIENOCYCLIC COMPOUND AND SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/767034 [patent_app_country] => US [patent_app_date] => 2018-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12728 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 366 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767034 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/767034
THIENOCYCLIC COMPOUND AND SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF Nov 22, 2018 Pending
Array ( [id] => 19246771 [patent_doc_number] => 20240197755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer [patent_app_type] => utility [patent_app_number] => 16/324881 [patent_app_country] => US [patent_app_date] => 2017-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4170 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324881 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/324881
Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer Oct 24, 2017 Abandoned
Menu